New Novartis drug may fundamentally change heart failure treatment

02 Sept 2014


Researchers from the University of Glasgow and University of Texas have published an eagerly awaited study in New England Journal of Medicine showing that a new drug from Novartis significantly reduces the number of death from heart failure when used to replace traditional drug cocktails. Press Release


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story